- ^ C Vézina, A Kudelski, S N Sehgal. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo). (1975)
- ^ E J Brown, et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature. (1994)
- ^ F Buttgereit, M D Brand. A hierarchy of ATP-consuming processes in mammalian cells. Biochem J. (1995)
- ^ Grace Y Liu, David M Sabatini. mTOR at the nexus of nutrition, growth, ageing and disease. Nat Rev Mol Cell Biol. (2020)
- ^ K Hara, et al. Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem. (1997)
- ^ Sebastian I Arriola Apelo, et al. Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell. (2016)
- ^ Joan B Mannick, et al. TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med. (2018)
- ^ Greenhaff PL, et al. Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle. Am J Physiol Endocrinol Metab. (2008)
Mammalian target of rapamycin (mTOR)
Our evidence-based analysis on mammalian target of rapamycin (mtor) features 8 unique references to scientific papers.
References
